Related Experiment Video
Updated: Feb 5, 2026
12:03
Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
5.0K
A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities
Basak Ozgen Saydam1, Melda Sonmez2, Ilgin Yildirim Simsir3
1a Division of Endocrinology and Metabolism , Dokuz Eylul University, Izmir.
Endocrine Research
|September 6, 2018
Summary
Acquired partial lipodystrophy (APL) patients can develop severe metabolic issues like uncontrolled diabetes and high triglycerides. These individuals may represent a distinct subgroup requiring specialized treatments beyond standard care.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Rare Diseases
Background:
- Acquired partial lipodystrophy (APL) is a rare condition marked by selective loss of adipose tissue.
- APL can lead to significant and severe metabolic complications.
Purpose of the Study:
- To identify and characterize a subset of APL patients experiencing severe metabolic abnormalities.
- To analyze the clinical features and disease progression in these APL patients.
Main Methods:
- Retrospective analysis of patients from a national lipodystrophy registry.
- Defined severe metabolic abnormalities including uncontrolled diabetes, hypertriglyceridemia, pancreatitis, and non-alcoholic steatohepatitis (NASH).
Main Results:
- Six APL patients with severe metabolic abnormalities were identified from 28 APL cases.
- Common issues included poorly controlled diabetes, severe hypertriglyceridemia, and hepatic steatosis (NASH in two).
- Advanced fat loss and longer disease duration were associated with these severe metabolic complications.
Conclusions:
- This subset of APL patients may represent a distinct group with unique therapeutic needs.
- Investigational therapies like metreleptin might be beneficial for these patients when standard treatments are insufficient.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
236
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
236
02:23Abnormal Proliferation
5.2K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.2K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
222
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
222
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
190
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
190
00:52What is Metabolism?
131.9K
Overview
131.9K
01:28Partial Fractions
224
A partial fraction is a component of a rational expression represented as the sum of simpler fractions. When a rational function is expressed as a ratio of two polynomials, it can often be decomposed into a sum of fractions whose denominators are simpler polynomials, typically linear or irreducible quadratic factors. This process is called partial fraction decomposition, and it is used to simplify complex expressions for integration, solving equations, or analysis.Partial fraction decomposition...
224